EDAP TMS S.A. American Depositary Shares
NASDAQ:FOCLMedical - Devices
-$0.10 today
- Market cap
- $116.19M
- Beta
- 0.00
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$0.82
Volume 0.16M
Average 0.04M
FOCL Net Income
Bottom-line profit, the starting point for calculating cash from operations.
EDAP TMS S.A. American Depositary SharesNASDAQ: FOCL
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income grows 22.4% year over year
Q1 FY2026 net income of $9.12M (cash outflow) rose 22.4% year over year. Sequentially, it fell 3.5% from the prior quarter. Over 3 fiscal years it compounded at +111.9% a year.
Context
- Net income amounted to 41.5% of revenue in FY2025, up 11.8 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of -$33.96M (+15.8%) for the fiscal year ending Dec 2026, a slowdown from the +42.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$9.12M-3.5% QoQ
- Last fiscal yearDec 2025
- -$29.34M+42.6% YoY
- LTMJun 2024
- -$21.25M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +22.4% | — | — |
| 1 year | +42.6% | +15.8% | -26.9 pp |
| 3-year CAGR | +111.9% | -9.4% | -121.3 pp |
| 5-year CAGR | -35.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (29.34M) USD
- Year-over-year change
- -42.6%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (29.34M) | -42.6% |
| FY2024 | 2024-12-31 | (20.57M) | +10.2% |
| FY2023 | 2023-12-31 | (22.9M) | -642.8% |
| FY2022 | 2022-12-31 | (3.08M) | -472.6% |
| FY2021 | 2021-12-31 | 827.39K | — |
Net Income vs competitors
How FOCL compares with its peers on the latest reported figures
No competitor Net Income figures are available to compare.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 827.39K | (3.08M) | (22.9M) | (20.57M) | (29.34M) |
| Depreciation & Amortization | 2.27M | 1.72M | 2.08M | 2.8M | 3.43M |
| Deferred Income Tax | (665.46K) | 50.45K | 45.41K | (104.92K) | (231.71K) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 615.81K | (4.54M) | (3.14M) | (2.12M) | 2.94M |
| Accounts Receivables | (121.74K) | (2.07M) | (5.31M) | (150.36K) | (568.75K) |
| Inventory | 196.21K | (4.71M) | (4.55M) | (4.37M) | 6.87M |
| Accounts Payables | (44.92K) | 1.2M | 5.71M | 1.34M | (2.97M) |
| Other Working Capital | 586.26K | 1.05M | 1.01M | 1.06M | (390.21K) |
| Other Non-Cash Items | 2.21M | 2.67M | 8.04M | 5.3M | 6.74M |
| Operating Cash Flow | 5.26M | (3.18M) | (15.87M) | (14.69M) | (16.46M) |
| Capital Expenditures | (464.52K) | (644.24K) | (1.27M) | (1.42M) | (4.94M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 15.37K | 0 | 1.08K | 0 | 0 |
| Other Investing Activities | (1.38M) | (1.71M) | (2.85M) | (2.79M) | 44.14K |
| Investing Cash Flow | (1.94M) | (2.5M) | (4.7M) | (4.46M) | (5.73M) |
| Debt Repayment | (1.73M) | (951.13K) | (1.27M) | 4.89M | 8.64M |
| Common Stock Issued | 25.69M | 23.8M | 282.17K | 125.48K | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.18K | (2.1K) | 1 | 0 | 0 |
| Financing Cash Flow | 23.95M | 22.85M | (984.9K) | 5.01M | 8.64M |
| Effect of Forex Changes | (3.83M) | (3.45M) | 2.19M | (2.99M) | 3.11M |
| Net Change in Cash | 23.44M | 13.73M | (19.36M) | (17.13M) | (10.44M) |
| Free Cash Flow | 4.79M | (3.82M) | (17.14M) | (16.12M) | (21.4M) |
EDAP TMS S.A. American Depositary Shares
NASDAQ:FOCL
Intrinsic Alpha fair value
Locked
Current Price
$3.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.